The Globe $lammed the door on me:
Moderna’s top doctor gets $1 million richer every week selling stock like clockwork
It's his piece of the pie, and the Chief Medical Officer Tal Zaks is taking it personally as the Globe hides the malfea$ance behind a STAT PAY WALL!!
Meanwhile, the bu$ine$$ section leads with two companion pieces regarding the testing for safety:
"Details of why volunteer fell ill during test of vaccine may take days to emerge; Johnson & Johnson, the developer with Beth Israel Deaconess, says an independent monitor is investigating" by Jonathan Saltzman Globe Staff, October 13, 2020
A late-stage study of a COVID-19 vaccine developed by Johnson & Johnson and Beth Israel Deaconess Medical Center has been paused as a result of a participant’s unexplained illness, marking at least the second such halt to occur among several vaccines that have reached final tests in the United States.
Executives at Johnson & Johnson provided no details Tuesday about the pause in the study, which is intended to ultimately enroll 60,000 volunteers. Indeed, they said they didn’t know whether the individual who suffered a serious adverse event received the vaccine or a placebo; that information is withheld from investigators and volunteers as part of the “double-blind” study design; nonetheless, the executives said it was not uncommon for volunteers in large clinical trials to get ill for reasons that have nothing to do with the studies. The company paused further dosing to let an independent safety monitoring panel and company doctors investigate the matter, including whether the volunteer received a placebo or the real thing. Company officials expected the inquiry to take at least a few days.
“What it should do also is reassure the public that every scientific, medical and ethical standard is being applied here not only at Johnson & Johnson but across the industry as we all search for a vaccine to combat COVID-19,” Joseph Wolk, executive vice president and chief financial officer for New Jersey-based J&J, said Tuesday on CNBC.
With all due respect, J&J is the same company that knew its talc powder caused ovarian cancer in women and didn't tell them for decades.
Beyond that, this has the stench of a rolled out presentation for the obviou$ rea$ons.
The J&J vaccine trial is expected to take place at up to 215 research sites, making it the largest late-stage coronavirus clinical trial to date. The sites include hospitals and clinics in the United States, Mexico, South America, Africa, Asia, and Europe. In Massachusetts, two sites are recruiting volunteers, at Massachusetts General Hospital and Brigham and Women’s Hospital.
Unlike several of the other 10 experimental vaccines that are in large-scale Phase 3 trials ― including one developed by the Cambridge biotech Moderna ― the J&J vaccine would offer protection from COVID-19 after one shot instead of two. The vaccine was developed partly by Beth Israel’s Center for Virology and Vaccine Research in Boston.
One-and-done will be a $elling point, and one will be far too much for a human.
It uses the human adenovirus, which causes the common cold, to deliver part of the spike protein of the SARS-CoV-2 virus into cells to stimulate antibodies. J&J used this approach to develop a vaccine against Ebola virus disease that recently won marketing authorization from the European Commission.
It's what we have been saying. The damn COVID is a mild flu that most recover from, and therefore this vaccination agenda is about something else entirely.
That’s the same approach for a vaccine developed by the British-Swedish drug maker AstraZeneca and the University of Oxford. A final-phase trial of that vaccine was stopped in September after at least one participant developed unexplained neurological symptoms. AstraZeneca has since resumed the studies everywhere except in the United States.
In a previously scheduled earnings call with analysts Tuesday, Mathai Mammen, the global head of research and development for the pharmaceutical arm of J&J, said he didn’t know whether the illness that triggered the latest pause was neurological. It will take at least a few days for the company to gather details, he said.
That means nerve damage or paralysis, and who wants to risk that over COVID?
He said the company expects to enroll 60,000 volunteers “in two or three months, and that remains on track.” The company remains “bullish” on the vaccine and believes it will prevent the coronavirus in at least 70 percent of people who receive it, he added.
Wait a minute, it ISN'T FOOLPROOF or provide FULL PROTECTION?!!
Then NO THANK YOU!!!
J&J has safely used an adenovirus-based vaccine to deliver a protein to simulate an immune response for 100,000 patients against diseases such as Ebola, according to Wolk.
“We’re very, very comfortable that we’ll be able to address this,” he said.
J&J executives also stressed that the company itself had imposed a “study pause,” while the halt in the AstraZeneca trial was a hold imposed by federal regulators.
--more--"
One of the Globe's printed ads was for a virtual event Saltzman is leading on October 15th, with one of the talking points "making sure everyone gets the vaccine."
"Eli Lilly’s antibody trial is paused over potential safety concern" by Katherine J. Wu New York Times, October 13, 2020
A government-sponsored clinical trial that is testing an antibody treatment for COVID-19 developed by drugmaker Eli Lilly has been paused because of a “potential safety concern,” according to e-mails that government officials sent Tuesday to researchers at testing sites. The company confirmed the pause.
Treatment would ruin it for vaccines, and there are already many treatments availble for a "disease" with a 99.98% survival rate.
The news comes just a day after Johnson & Johnson announced the pause of its coronavirus vaccine trial because of a sick volunteer and a month after AstraZeneca’s vaccine trial was halted over concerns about two participants who had fallen ill after getting the company’s vaccine.
The Eli Lilly trial was designed to test the benefits of the antibody therapy on hundreds of people hospitalized with COVID-19, compared with a placebo. All of the study participants also received another experimental drug, remdesivir, which has become commonly used to treat coronavirus patients. It is unclear how many volunteers were sick and what the details of their illnesses were.
I don't know about you, but I DO NOT want to be EXPERIMENTED UPON!
In large clinical trials, such pauses are not unusual, and illnesses in volunteers are not necessarily the result of the experimental drug or vaccine. Such halts are meant to allow an independent board of scientific experts to review the data and determine whether the event may have been related to the treatment or occurred by chance.
“This is why clinical trials are essential,” said Marion Pepper, an immunologist at the University of Washington. “The safety of the product has to be empirically proven.”
PFFFT!
This is PUBLIC RELATIONS PROPAGANDA!
Without more details on the nature of the illnesses that may have prompted the pause, however, the seriousness of the event remains unclear, Pepper added.
Enrollment for the Eli Lilly trial, which was sponsored by several branches of the National Institutes of Health and the Department of Veterans Affairs, among other organizations, had been continuing, but Tuesday, multiple officials sent e-mails to researchers telling them to stop adding volunteers to the study out of an “abundance of caution.”
That's the NEW BUZZWORD to justify all sorts of things, including future lockdowns.
Several experts praised the trial’s sponsors for halting the trial to address the safety of their product, as AstraZeneca and Johnson & Johnson have done with their vaccines. “They are doing things by the book,” said Dr. Maricar Malinis, an infectious disease physician at Yale.
Which one, the WHO or Rockefeller?
Eli Lilly is one of several companies pursuing experimental treatments for COVID-19 that use monoclonal antibodies — mass-produced mimics of immune molecules the human body produces in reaction to the coronavirus.
Eli Lilly’s product is similar to a treatment designed by drug company Regeneron, which developed an antibody therapy given to President Trump after he tested positive for the coronavirus this month. Trump has promoted the treatments, without evidence, as a “cure” for his condition and has suggested that their approval and widespread distribution could be imminent.
Then it won't work, and their stock rose along with some Trump interests on that news.
Hmmm.
The week after the president was treated, both companies applied for emergency clearance for their products from the Food and Drug Administration. (Eli Lilly has applied for authorization of its drug for mild or moderate cases of COVID-19, not for use in hospitalized patients like those enrolled in the halted trial.)
The company is also trialing its antibody treatment in people who have recently tested positive for the coronavirus, and in nursing home residents and workers who may have been exposed.
MAY HAVE been exposed?
Beyond that, the PCR tests are flawed and not meant to detect COVID-19.
They are turning up false positives based on any common cold you ever had, it just depends on how many times they amplify your material.
Antibodies can block the coronavirus from infecting cells, and preliminary data from Eli Lilly and Regeneron have hinted that the immunity-mimicking treatments may be able to tamp down the amount of virus in infected people and reduce their symptoms. Eli Lilly also hopes to collect data to figure out whether antibodies can protect certain people from developing COVID-19 after encountering the virus.
Still, if monoclonal antibodies end up being linked to an unexpected side effect — which has not yet been conclusively shown — it will be crucial to figure out how and why these immune molecules are sickening people, said Akiko Iwasaki, an immunologist at Yale.
The news of the trial’s pause prompted a small decline in Eli Lilly’s stock Tuesday afternoon.....
That's the mo$t important thing, the health of the company's $tock.
--more--"
$peaking of $tocks:
"Banks and technology companies led a broad slide for stocks Tuesday on Wall Street, snapping the market's four-day winning streak. The S&P 500 lost 0.6%, giving back some of its gains from a day earlier. Many forces are pushing and pulling on markets: Coronavirus counts are rising in many countries, and Johnson & Johnson had to temporarily pause a late-stage study of a potential vaccine. Uncertainty about the prospects for more stimulus for the economy from Washington continues to hang over markets. Still, stocks have been mostly pushing higher this month. Major indexes have recouped their losses from September's market swoon. Tuesday's slide came as the third-quarter earnings reporting season got underway. Wall Street expects a sharp drop in quarterly profits, nearly 21% for S&P 500 earnings per share from a year earlier, but that would not be as bad as the nearly 32% plunge for the spring. Several companies kicked the season off on Tuesday with better-than-expected reports; their stocks, though, closed mixed. BlackRock rose 3.9%, while JPMorgan Chase and Citigroup fell 1.6% and 4.8%, respectively. Johnson & Johnson dropped 2.3% and Eli Lilly fell 2.9%. Delta Air Lines reported a worse loss than Wall Street had forecast, as the pandemic keeps many flyers grounded, and its shares slid 2.7%. Royal Caribbean's 13.2% loss was the S&P 500's biggest. On the winning side was the Walt Disney Co., which climbed 3.2% for one of the bigger gains in the S&P 500 after it announced a major reorganization of its company to focus on Disney Plus and its other streaming services....."
Maybe you would like to inve$t in a pair of Red Sox?
"John Henry’s Fenway Sports Group is having a moment. Not only is the parent company of the Red Sox negotiating a deal that would put it on the New York Stock Exchange, just like Walmart or Warren Buffett’s Berkshire Hathaway, but “Moneyball” legend Billy Beane may leave the Oakland Athletics and Major League Baseball to join the FSG effort, according to The Wall Street Journal. The talks may not end with a handshake, but the estimated $1.5 billion FSG would get from a special purpose acquisition company, or SPAC, called RedBall Acquisition Corp., which Beane cochairs in addition to his current job as executive vice president of baseball operations and part owner of the A’s, and other investors would give Henry (who also owns the Globe) the financial flexibility to expand the company, which includes its English gem, Premier League champion Liverpool Football Club. There’s even a Yankees twist. (More on that later.) Savvy investors may understand how the process of raising money and going public through a SPAC works, but the average Red Sox fan is likely to have questions, especially about the potential for them to buy stock in the team. We try to answer some of those questions here....."
So am I, and I am out of an$wers.
Time to go back to the office -- or not:
"July is the new January: More companies delay return to the office" by Gillian Friedman and Kellen Browning New York Times, October 13, 2020
When the coronavirus pandemic shuttered offices around the United States in March, many companies told their employees that it would be only a short hiatus away from headquarters.
Almost all believed and bought in, thus the Great Re$et ball got rolling.
Don't you remember when we were told two weeks to flatten a curve that never came?
Yet here are, seven months later and heading into another lockdown based on complete lies.
CUI BONO?
Workers, they said, would be back in their cubicles within a matter of weeks. Weeks turned into September. Then September turned into January, and now, with the virus still surging in some parts of the country, a growing number of employers are delaying return-to-office dates once again, to the summer of 2021 at the earliest.
If the virus is still surging then the lockdowns failed and simply kept the virus alive while denying us herd immunity.
Of course, the surging caseload belies that fact and would signal that herd immunity has been achieved as the mon$ters behind this thing continue to peddle outrageous falsehoods and lies.
Google was one of the first to announce that July 2021 was its return-to-office date. Uber, Slack, and Airbnb soon jumped on the bandwagon. In the past week, Microsoft, Target, Ford Motor Co., and The New York Times said they, too, had postponed the return of in-person work to next summer and acknowledged the inevitable: The pandemic isn’t going away anytime soon.
I'm told “we are going to be living with COVID until there is a vaccine or a treatment” by the most evil of men.
“Let’s just bite the bullet,” said Joan Burke, the chief people officer of DocuSign in San Francisco. In August, her company, which manages electronic document signatures, decided it would allow its 5,200 employees to work from home until June 2021.
“We’re still in a place where this is evolving,” she said. “None of us have all the answers.”
Many more companies are expected to delay their return-to-office dates to keep workers safe, and workers said they were in no rush to go back, with 73 percent of US employees fearing that being in their workplace could pose a risk to their personal health and safety, according to a study by Wakefield Research commissioned by Envoy, a workplace technology company.
Yeah, I have kind of given up on the American people and wait until they find out there is no job to go back to.
More companies are also saying that they will institute permanent work-from-home policies so employees do not ever have to come into the office again.
That's the end result of the transition to the globali$ts technocratic dystopia.
If true, then WHY the NEED for a VACCINE or TREATMENT at all?
This is NO LONGER ABOUT COVID!
It's a COVID cover for the GREAT RE$ET!
In May, Facebook was one of the first to announce that it would allow many employees to work remotely even after the pandemic. Twitter, Coinbase, and Shopify have also said they would do so. On Friday, Microsoft announced it would also be part of that shift.
--more--"
Related:
Mass. tech group names executives to its board
Also see:
Eversource completes purchase of Columbia Gas
Con$olidating the $pew are the oligarchs before complete global communism takes over.
Raytheon begins job cuts as virus guts jet-engine demand
I guess that means no more going to the movies:
"AMC Entertainment Holdings Inc. said it may soon run out of cash amid fresh signs that the pandemic is pushing cinema operators close to default. The world’s biggest theater chain said in a filing Tuesday that liquidity will be largely depleted by the end of this year or early next year if attendance doesn’t pick up, and it’s exploring actions that include asset sales and joint ventures. Attendance since the resumption of business in the United States is down 85 percent from the same period a year ago, the company said. AMC has been hobbled by the coronavirus outbreak, which discourages some moviegoers from coming and studios from releasing blockbusters that might attract them. AMC is looking for sources of liquidity to ride out the pandemic, including asset sales and joint ventures, but cautions there is “significant risk” that its efforts may fall short or fail. Cineworld Group Plc, owner of the Regal chain, earlier this month suspended operations at its US and UK locations because of the lack of big movies. AMC pledged to stay open, citing releases of less ambitious movies still on the schedule such as “The War With Grandpa.” Illustrating the industry’s woes, that Robert De Niro vehicle opened with a paltry weekend gross of $3.6 million in North America. AMC has resumed operations at just under 500 of its 598 US theaters with limited capacity, the company said."
Even though I hate the filth they trowel out and rarely ever went these last few years, it is saddening to realize there will no longer be the option to see things on the big screen because some of my best memories come from the theater.
On the other hand, the studios have quietly resumed production without masks or distancing while you were all being browbeaten with lies all summer regarding cases:
Related:
"Netflix Inc. is facing a criminal charge in Texas over its promotion of “Cuties,” a controversial French coming-of-age movie that premiered on the streaming service last month. Tyler County District Attorney Lucas Babin said a grand jury returned an indictment charging the company with felony promotion of lewd visual material depicting a child. The Texas county, located about two hours northeast of Houston, has a population of around 21,000. “Cuties” depicts an 11-year-old French-Senegalese girl in Paris rebelling against her conservative Muslim family by joining a dance crew with other girls. It’s become a lightning rod among conservatives, and thousands of subscribers have threatened to cancel because of the film’s depiction of young girls in skimpy clothes dancing in suggestive ways. In a statement, Netflix defended the film by French-Senegalese director Maïmouna Doucouré. “'Cuties' is a social commentary against the sexualization of young children,” a company spokesperson said. “This charge is without merit and we stand by the film.” Babin, a Republican voted into office in 2018, said in a statement that he brought the charge after watching the film. “If such material is distributed on a grand scale, isn’t the need to prosecute more, not less?” said the district attorney, the son of Texas Republican Congressman Brian Babin and a former actor who played one of Jack Black’s antagonists in 2003′s “School of Rock.”
Also see: Here’s Exactly What Mass Media is Praising
Like I said, filth, and in this case vile pedophilia.
Of course, such musing are considered "conspiracy theories" even though they are right in front of our faces, while the pre$$ continues to promote this rubbish:
"A town in the Republic of North Macedonia that became infamous for churning out disinformation ahead of the 2016 US presidential election is at it again. The town, Veles, is now hosting a crop of popular new websites that are purporting to be US conservative news outlets and are publishing dubious and misleading information, according to a report released Tuesday by the Election Integrity Partnership, a group of research organizations studying misinformation campaigns. The websites have gained some viral success on conservative social media feeds, according to the report. The sites, which included names like Resist the Mainstream, mainly specialized in copying and republishing content from conservative news outlets in the US, including conspiracy theories and misinformation about topics such as voting fraud. The creators of the fake sites targeted a social media service called Parler that is popular with supporters of right-wing causes. They likely chose Parler because of crackdowns by Facebook and Twitter on misinformation, the researchers said. The report adds to a growing body of evidence that America’s political divisions are good business for foreign click-bait factories, bringing in ad dollars whether the content is fake news, hyper-partisan, or a mixture of both. It also highlights the ongoing difficulty that US voters face in discerning trustworthy sources and the veracity of their news received through social media."
One place we know we can't trust is the ma$$ media and pre$$ that drives divisions more than any foreign government, and here is another one that has the feel of a layered limited hangout for agenda-pushing purposes:
"Another ‘Unfounded’ Study on Origins of Virus Spreads Online" by Katherine J. Wu, New York Times, October 13 2020
An overwhelming body of evidence continues to affirm that the coronavirus almost certainly made its hop into humans from an animal source — as many, many other deadly viruses are known to do, but since the early days of the pandemic, experts have had to fight to combat misinformed rumors that the coronavirus emerged from a lab as part of a sinister scientific project.
My evolution has been from bioweapon released by America to COVID is a complete myth.
The way they New York Times chose to introduce this article convinces me of that fact even further.
Last week, yet another piece of unfounded and misleading prose entered the fray: a study, posted online but not published in a peer-reviewed scientific journal, contending that the virus is artificial and an “unrestricted bio-weapon” released by Chinese researchers.
I'm not discounting a Chinese release, but they themselves are not capable of instituting lockdown polices on western governments. The plot is larger than them.
Beyond that are the flawed tests, survival rate, diminished death tolls, the failure to isolate it, and the rest, that indicate absolute fraud with this eye-opening piece a piece of pure propaganda.
The manuscript also baselessly denounced several parties, including policymakers, scientific journals and even individual researchers, for censoring and criticizing the lab-made hypothesis, accusing them of deliberate obfuscation of fact and “colluding” with the Chinese Communist Party.
Provides the basis to wage war on them, doesn't it?
This as my country becomes something worse than China ever dreamed.
Though scientists immediately condemned the study as disreputable and dangerous, it rapidly commanded a storm of social media attention, garnering more than 14,000 likes on Twitter and more than 12,000 retweets and quote-tweets within days of its posting. Shared on Facebook, Twitter and Reddit, it reached millions of users, and was covered in at least a dozen articles written in several languages.
The paper’s findings, however, have no basis in science.
“It’s ridiculous and unfounded,” said Angela Rasmussen, a virologist at Columbia University who criticized the study on Twitter the day it was released. “It’s masquerading as scientific evidence, but really it’s just a dumpster fire.”
I rest my case.
The publication is the second in a series from a team led by Li-Meng Yan, a Chinese scientist who released an initial paper on Sept. 14, also not peer-reviewed, asserting that the coronavirus was synthetic. Dr. Yan’s background is a little murky. She left her position as a postdoctoral research fellow at Hong Kong University for undisclosed reasons some time ago, according to a July statement from the institution, and fled to the United States. Both papers list Dr. Yan and her co-authors as affiliated with the Rule of Law Society, a nonprofit whose founders include Steve Bannon, a former White House chief strategist, who has since been charged in an unrelated case of fraud.
“That alone should give people pause,” Dr. Rasmussen said of the team’s connection to Mr. Bannon’s nonprofit.
Same with those that hung around Epstein, but you know!
New York Times sat on that and Weinstein but took the hatchet out here!
Dr. Yan and her colleagues did not respond to a request for comment.
Their original paper — known as “the Yan report” — was also seized upon by thousands online and reported on in The New York Post, even though experts rapidly debunked its findings. Researchers called it unscientific and said it ignored the wealth of data pointing to the virus’s natural origins.
Close relatives of the new coronavirus exist in bats. The virus may have moved directly into people from bats, or first jumped into another animal, such as a pangolin, before transitioning into humans. Both scenarios have played out before with other pathogens.
“We have a very good picture of how a virus of this kind could circulate and spill over into human beings,” said Brandon Ogbunu, a disease ecologist at Yale University.
It may take quite some time to pinpoint exactly which animals harbored the virus along this chain of transmission, if scientists ever do at all — inevitably leaving some parts of the virus’s origin story ambiguous. Like many other conspiracy theories, the lab-made hypothesis “exploits the open questions in an ongoing investigation,” Dr. Ogbunu said, but there is no evidence so far to support a synthetic source for the virus.
Dr. Yan’s Twitter account was suspended in September 2020 for pushing coronavirus disinformation. She shared the “second Yan report” from a second Twitter account, which has gained more than 34,000 followers.
Together, the papers written by Dr. Yan and her colleagues lay out what they identified as abnormalities in the genome sequence of the coronavirus. They suggested that those unusual features indicated that the virus’s genome had been purposefully spliced together and modified, using the genetic material from other viruses — a sort of Frankenstein’s monster pathogen, Dr. Yan told Fox News in September. The cousins of the coronavirus that had been identified in bats, they said, were also fake, human-made constructions, thus supposedly quashing the natural origin hypothesis.
That was put out there at the beginning and I bought in, but now I realize it was something to muddy the waters.
The authors also contended that the coronavirus’s genome had been manipulated by scientists to enhance the virus’s ability to infect human cells and cause disease, but outside experts have found no validity in either Yan report. The first was “full of contradictory statements and unsound interpretations” of genetic data from viruses, said Kishana Taylor, a virologist at Carnegie Mellon University, and the second Yan report “was even more unhinged than the first,” said Gigi Kwik Gronvall, a senior scholar at the Johns Hopkins Center for Health Security and an author of a response debunking the original Yan report.
The supposedly strange features found in the genomes of the coronavirus and its natural relatives aren’t actually red flags at all, Dr. Ogbunu said. Viruses frequently move between animal hosts, changing their genetic material along the way — sometimes even swapping hunks of their genomes with other viruses, and many of the purported abnormalities in the coronavirus are found in other virus genomes.
The notion that the coronavirus was “designed” to be dangerous is also “just nonsense,” Dr. Ogbunu said. Scientists don’t know enough about viruses to predict which mutations would increase their lethality, let alone engineer these changes into new pathogens in the lab.
Building the coronavirus from such a mishmash of genetic templates, as described by Dr. Yan and her colleagues, would also raise herculean logistical hurdles for even the most dogged scientists. Part of this process would require researchers to laboriously tinker with thousands of individual letters in the alphabet soup that is a virus’s genome — an absurdly inefficient scientific strategy, Dr. Rasmussen said.
“Extraordinary claims require extraordinary evidence,” Dr. Rasmussen said, “and this is not that.”
Like the New York Times was or is ever interested in evidence.
--more--"
Related:
China and Russia win seats on UN rights council
It's a loss for the United States.
